Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6orf89 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | IFT122 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | INIP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | AC087762.1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TRIM39 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | NEURL3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | USP30 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | KLHDC4 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | TRAF3IP2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |